SPD Warns German Health Reform Will Overburden Insured

The Social Democratic Party (SPD) has voiced strong opposition to the government's planned health insurance reform, cautioning that the measures will disproportionately burden citizens. According to the SPD's health policy spokesperson, Christos Pantazis, the core issue within the statutory health insurance system lies in its expenditures, not its revenue. He criticizes Health Minister Nina Warken (CDU) for inadequately considering expert recommendations for the austerity package.

“

Aus unserer Sicht liegt das zentrale Problem der gesetzlichen Krankenversicherung auf der Ausgabenseite, nicht auf der Einnahmenseite

Key proposals within Warken's draft legislation include spending brakes on medical practices, hospitals, and the pharmaceutical sector, alongside increased co-payments for medications and restrictions on spousal insurance. SPD General Secretary Tim Klüssendorf specifically called for greater financial responsibility from pharmaceutical corporations, highlighting Germany's high per capita drug expenses in Europe. He urged the reform to target drug prices directly rather than shifting the financial burden onto families and policyholders.

“

Ein großer Hebel liegt bei den Arzneimitteln

Former Health Minister Karl Lauterbach (SPD) expressed concerns about a potential two-tiered healthcare system, fearing that rising co-payments might deter individuals with lower incomes from seeking necessary treatments. He also warned that capped budgets for doctors could lead to reduced appointment availability for the publicly insured, potentially benefiting those with private insurance more. Meanwhile, the Green Party has presented an alternative plan, suggesting that contribution rates could remain stable or even decrease if health costs for recipients of citizen's welfare benefits were covered by the state budget.

“

Wenn die Zuzahlungen steigen, wird der eine oder andere auf notwendige Behandlungen verzichten